Baidu
map

Int J Cardiol:保持心脏健康指标,还能预防癌症死亡!全国4.6万人10年随访研究

2020-04-29 朱朱 中国循环杂志

北京大学第一医院肾内科张路霞教授等针对近4.6万名中国成年人进行约10年的随访观察后发现,保持理想的心血管健康指标,不仅可降低心血管死亡风险,还能降低癌症死亡和全因死亡风险。

北京大学第一医院肾内科张路霞教授等针对近4.6万名中国成年人进行约10年的随访观察后发现,保持理想的心血管健康指标,不仅可降低心血管死亡风险,还能降低癌症死亡和全因死亡风险。

研究者指出,我国应倡导在人群水平评估心血管健康指标。

根据美国心脏协会定义,理想心血管健康指标包括7项,即“生命简单7法则”:不吸烟、维持健康体重、规律运动、健康饮食、理想的胆固醇水平(非治疗下状态下<200 mg/dl)、理想的血压水平(非治疗状态下<120/80 mmHg)和理想的血糖水平(非治疗状态下空腹血糖<100 mg/dl)。

该研究选取除规律运动、健康饮食的其他5个心血管健康指标进行了评估分析。

多因素Cox回归分析显示,平均9.7年随访期间,与那些没有或仅有1个理想心血管健康指标的人相比,有4~5个理想心血管健康指标的成年人中不仅心血管死亡风险降低了59%,全因死亡和癌症死亡风险也分别降低了42%和62%。

校正潜在混淆因素后,不吸烟(包括戒烟至少1个月)和维持理想的空腹血糖水平可显着降低心血管死亡风险;不吸烟和维持理想的总胆固醇水平可显着降低全因死亡风险。

该研究数据来源于于2007年1月至2010年9月期间开展的一项具有全国代表性的调查研究,共纳入45 984名既往无心血管病史的成年人,其平均年龄为49.2岁。

45.2%的成年人拥有4~5个理想心血管健康指标,女士中情况好于男士(56.2% vs 35.9%)。维持理想血压水平的人不足1/3。

随访期间,共1451人死亡,其中541人死于心血管病,555人死于癌症,181例死于其他慢性非传染性疾病。

原始出处:Gao B, Wang F, Zhu M, et al. Cardiovascular Health Metrics and All-Cause Mortality and Mortality From Major Non-Communicable Chronic Diseases Among Chinese Adult Population. Int J Cardiol, 2020 Apr 19

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1782082, encodeId=0e881e8208267, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Nov 30 16:06:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716551, encodeId=9a621e16551dc, content=<a href='/topic/show?id=afa5984e47a' target=_blank style='color:#2F92EE;'>#随访研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98474, encryptionId=afa5984e47a, topicName=随访研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c1232248438, createdName=habb, createdTime=Sun Sep 13 15:06:39 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045366, encodeId=32bf20453660a, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Tue Aug 18 15:06:39 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928330, encodeId=de5f1928330e5, content=<a href='/topic/show?id=4c6c2e82642' target=_blank style='color:#2F92EE;'>#健康指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27826, encryptionId=4c6c2e82642, topicName=健康指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Aug 28 23:06:39 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488070, encodeId=415b14880e0f3, content=<a href='/topic/show?id=5c699e46010' target=_blank style='color:#2F92EE;'>#防癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97460, encryptionId=5c699e46010, topicName=防癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6d78400961, createdName=jeanqiuqiu, createdTime=Thu Apr 30 17:06:39 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515065, encodeId=599415150654f, content=<a href='/topic/show?id=3806514304b' target=_blank style='color:#2F92EE;'>#心脏健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51430, encryptionId=3806514304b, topicName=心脏健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c810711035, createdName=1179102698_36768929, createdTime=Thu Apr 30 17:06:39 CST 2020, time=2020-04-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1782082, encodeId=0e881e8208267, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Nov 30 16:06:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716551, encodeId=9a621e16551dc, content=<a href='/topic/show?id=afa5984e47a' target=_blank style='color:#2F92EE;'>#随访研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98474, encryptionId=afa5984e47a, topicName=随访研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c1232248438, createdName=habb, createdTime=Sun Sep 13 15:06:39 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045366, encodeId=32bf20453660a, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Tue Aug 18 15:06:39 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928330, encodeId=de5f1928330e5, content=<a href='/topic/show?id=4c6c2e82642' target=_blank style='color:#2F92EE;'>#健康指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27826, encryptionId=4c6c2e82642, topicName=健康指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Aug 28 23:06:39 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488070, encodeId=415b14880e0f3, content=<a href='/topic/show?id=5c699e46010' target=_blank style='color:#2F92EE;'>#防癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97460, encryptionId=5c699e46010, topicName=防癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6d78400961, createdName=jeanqiuqiu, createdTime=Thu Apr 30 17:06:39 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515065, encodeId=599415150654f, content=<a href='/topic/show?id=3806514304b' target=_blank style='color:#2F92EE;'>#心脏健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51430, encryptionId=3806514304b, topicName=心脏健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c810711035, createdName=1179102698_36768929, createdTime=Thu Apr 30 17:06:39 CST 2020, time=2020-04-30, status=1, ipAttribution=)]
    2020-09-13 habb
  3. [GetPortalCommentsPageByObjectIdResponse(id=1782082, encodeId=0e881e8208267, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Nov 30 16:06:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716551, encodeId=9a621e16551dc, content=<a href='/topic/show?id=afa5984e47a' target=_blank style='color:#2F92EE;'>#随访研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98474, encryptionId=afa5984e47a, topicName=随访研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c1232248438, createdName=habb, createdTime=Sun Sep 13 15:06:39 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045366, encodeId=32bf20453660a, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Tue Aug 18 15:06:39 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928330, encodeId=de5f1928330e5, content=<a href='/topic/show?id=4c6c2e82642' target=_blank style='color:#2F92EE;'>#健康指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27826, encryptionId=4c6c2e82642, topicName=健康指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Aug 28 23:06:39 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488070, encodeId=415b14880e0f3, content=<a href='/topic/show?id=5c699e46010' target=_blank style='color:#2F92EE;'>#防癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97460, encryptionId=5c699e46010, topicName=防癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6d78400961, createdName=jeanqiuqiu, createdTime=Thu Apr 30 17:06:39 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515065, encodeId=599415150654f, content=<a href='/topic/show?id=3806514304b' target=_blank style='color:#2F92EE;'>#心脏健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51430, encryptionId=3806514304b, topicName=心脏健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c810711035, createdName=1179102698_36768929, createdTime=Thu Apr 30 17:06:39 CST 2020, time=2020-04-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1782082, encodeId=0e881e8208267, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Nov 30 16:06:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716551, encodeId=9a621e16551dc, content=<a href='/topic/show?id=afa5984e47a' target=_blank style='color:#2F92EE;'>#随访研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98474, encryptionId=afa5984e47a, topicName=随访研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c1232248438, createdName=habb, createdTime=Sun Sep 13 15:06:39 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045366, encodeId=32bf20453660a, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Tue Aug 18 15:06:39 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928330, encodeId=de5f1928330e5, content=<a href='/topic/show?id=4c6c2e82642' target=_blank style='color:#2F92EE;'>#健康指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27826, encryptionId=4c6c2e82642, topicName=健康指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Aug 28 23:06:39 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488070, encodeId=415b14880e0f3, content=<a href='/topic/show?id=5c699e46010' target=_blank style='color:#2F92EE;'>#防癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97460, encryptionId=5c699e46010, topicName=防癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6d78400961, createdName=jeanqiuqiu, createdTime=Thu Apr 30 17:06:39 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515065, encodeId=599415150654f, content=<a href='/topic/show?id=3806514304b' target=_blank style='color:#2F92EE;'>#心脏健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51430, encryptionId=3806514304b, topicName=心脏健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c810711035, createdName=1179102698_36768929, createdTime=Thu Apr 30 17:06:39 CST 2020, time=2020-04-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1782082, encodeId=0e881e8208267, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Nov 30 16:06:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716551, encodeId=9a621e16551dc, content=<a href='/topic/show?id=afa5984e47a' target=_blank style='color:#2F92EE;'>#随访研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98474, encryptionId=afa5984e47a, topicName=随访研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c1232248438, createdName=habb, createdTime=Sun Sep 13 15:06:39 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045366, encodeId=32bf20453660a, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Tue Aug 18 15:06:39 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928330, encodeId=de5f1928330e5, content=<a href='/topic/show?id=4c6c2e82642' target=_blank style='color:#2F92EE;'>#健康指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27826, encryptionId=4c6c2e82642, topicName=健康指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Aug 28 23:06:39 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488070, encodeId=415b14880e0f3, content=<a href='/topic/show?id=5c699e46010' target=_blank style='color:#2F92EE;'>#防癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97460, encryptionId=5c699e46010, topicName=防癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6d78400961, createdName=jeanqiuqiu, createdTime=Thu Apr 30 17:06:39 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515065, encodeId=599415150654f, content=<a href='/topic/show?id=3806514304b' target=_blank style='color:#2F92EE;'>#心脏健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51430, encryptionId=3806514304b, topicName=心脏健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c810711035, createdName=1179102698_36768929, createdTime=Thu Apr 30 17:06:39 CST 2020, time=2020-04-30, status=1, ipAttribution=)]
    2020-04-30 jeanqiuqiu
  6. [GetPortalCommentsPageByObjectIdResponse(id=1782082, encodeId=0e881e8208267, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d7532500500, createdName=12499e01m47暂无昵称, createdTime=Mon Nov 30 16:06:39 CST 2020, time=2020-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1716551, encodeId=9a621e16551dc, content=<a href='/topic/show?id=afa5984e47a' target=_blank style='color:#2F92EE;'>#随访研究#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=98474, encryptionId=afa5984e47a, topicName=随访研究)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9c1232248438, createdName=habb, createdTime=Sun Sep 13 15:06:39 CST 2020, time=2020-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2045366, encodeId=32bf20453660a, content=<a href='/topic/show?id=7e4de13990f' target=_blank style='color:#2F92EE;'>#癌症死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71399, encryptionId=7e4de13990f, topicName=癌症死亡)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f7770, createdName=jeanqiuqiu, createdTime=Tue Aug 18 15:06:39 CST 2020, time=2020-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1928330, encodeId=de5f1928330e5, content=<a href='/topic/show?id=4c6c2e82642' target=_blank style='color:#2F92EE;'>#健康指标#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=27826, encryptionId=4c6c2e82642, topicName=健康指标)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f98e185, createdName=psybestwish, createdTime=Fri Aug 28 23:06:39 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1488070, encodeId=415b14880e0f3, content=<a href='/topic/show?id=5c699e46010' target=_blank style='color:#2F92EE;'>#防癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97460, encryptionId=5c699e46010, topicName=防癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f6d78400961, createdName=jeanqiuqiu, createdTime=Thu Apr 30 17:06:39 CST 2020, time=2020-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1515065, encodeId=599415150654f, content=<a href='/topic/show?id=3806514304b' target=_blank style='color:#2F92EE;'>#心脏健康#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=51430, encryptionId=3806514304b, topicName=心脏健康)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0c810711035, createdName=1179102698_36768929, createdTime=Thu Apr 30 17:06:39 CST 2020, time=2020-04-30, status=1, ipAttribution=)]

相关资讯

JACC:中老年人睡眠忽长忽短、忽早忽晚,心脏要惨

近期,《美国心脏病学会杂志》(JACC)发表一项前瞻性研究“Sleep Irregularity and Risk of Cardiovascular Events”首次证实:

NEJM:累及心脏的血管肉瘤-病例报道

对病变的活检标本进行检查后发现为高级别血管肉瘤。该患者进行了肿瘤切除手术,并计划接受辅助化疗。然而,其血液动力学不稳定,尽管接受了最大程度的支持治疗,患者仍在重症监护病房死亡。

Thyroid:甲状腺功能与肝脏、心脏和肺脏纤维化风险

这项研究表明甲状腺功能低下与肝脏、心脏和肺脏慢性纤维化疾病的可能性增加有关。但是,证据主要基于横截面数据。需要进行前瞻性研究和随机临床试验来探究甲状腺激素及其类似物对纤维化发生发展的潜在功效。

Radiology:真香的心脏BOLD序列你不要试一下嘛?

心肌氧合成像有助于评价微小血管功能异常,其与心血管不良事件风险具有相关性。然而,利用非侵入性心脏MRI血氧水平依赖(BOLD)来评价小血管氧合作用变化尚具有挑战性。

circulation: 哈佛研究报告:豆腐可以保护心脏

经常食用富含异黄酮的豆腐和其他植物性食品,可以降低患致命性或非致命性冠心病(CHD)的长期风险,对年轻女性而言,效果更显著。这是对三项前瞻性队列研究数据的汇总分析得出的结论。

Br J Anaesth:老年患者心脏手术后谵妄与术后脑供氧不足有关

近红外光谱可无创测量局部脑氧饱和度。术中脑供氧不足与较差的神经预后相关。本研究旨在探讨老年患者心脏手术后谵妄是否与围手术期脑氧饱和度降低有关。

Baidu
map
Baidu
map
Baidu
map